NCT00648063View on ClinicalTrials.gov

Fasting Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

December 31, 2005

Study Completion Date

January 31, 2006

Conditions
Healthy
Interventions
DRUG

Letrozole Tablets 2.5 mg

2.5mg, single dose fasting

DRUG

Femara® Tablets 2.5 mg

2.5mg, single dose fasting

Trial Locations (1)

33181

SFBC International, Miami

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648063 - Fasting Study of Letrozole Tablets 2.5 mg and Femara® Tablets 2.5 mg | Biotech Hunter | Biotech Hunter